![David L. Bellitt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David L. Bellitt
No más puestos en curso
Perfil
David L.
Bellitt has been President of Celliance Corporation since November 2004.
He was Vice President of Global Commercial Operations for Celliance Corporation from January 2003 to 2004.
From October 2000 to October 2002, he was Senior Vice President of Aksys, Ltd.
From June 1997 to November 1999, he was Senior Vice President of Akzo Nobel.
He received a BS in biology and chemistry from California State University.
Antiguos cargos conocidos de David L. Bellitt.
Empresas | Cargo | Fin |
---|---|---|
Celliance Corp.
![]() Celliance Corp. BiotechnologyHealth Technology Celliance Corp. used to develop and manufacture bioprocess products. It also offered bioprocess products and services including contract research, manufacturing services and cell culture media supplements. The company was located in Norcross, GA. | Presidente | - |
Serologicals Corp.
![]() Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Corporate Officer/Principal | - |
Formación de David L. Bellitt.
California State University-Fullerton | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Serologicals Corp.
![]() Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Commercial Services |
Celliance Corp.
![]() Celliance Corp. BiotechnologyHealth Technology Celliance Corp. used to develop and manufacture bioprocess products. It also offered bioprocess products and services including contract research, manufacturing services and cell culture media supplements. The company was located in Norcross, GA. | Health Technology |
- Bolsa de valores
- Insiders
- David L. Bellitt